2025 Program

Cambridge VIP’s Inaugural

Radiopharmaceuticals Venture, Innovation & Partnering Summit

Connecting Investors, Business Leaders, and Strategics to Accelerate Radiopharmaceuticals Innovation

October 1, 2025

 

Join us for an exclusive gathering of senior-level investors, corporate executives, entrepreneurs, and strategics at the Inaugural Radiopharmaceuticals Venture, Innovation & Partnering Summit, October 1, 2025, in Boston, MA. Connect with future partners and investors at intimate networking sessions; gain strategic insights on funding activities, business development, and innovation strategies in radiopharmaceuticals from industry-led panels; hear candid perspectives from radiopharma thought leaders during dynamic fireside chats; and catch up on innovative technologies presented by emerging companies. Building on the successful launch of the Oncology VIP Summit in 2024, this boutique event is positioned as the premier meeting place for key radiopharmaceuticals stakeholders to foster meaningful connections, acquire valuable strategic insights, and drive innovation and collaboration. The meeting is co-located with 2nd Annual Oncology Venture, Innovation & Partnering Summit, September 29-30.

 

Coverage will include, but is not limited to:

 

  • Future investment opportunities in radiopharmaceuticals and key learnings from early investments
  • Understanding and managing risk in radiopharmaceutical development
  • What conditions need to be met for a radiopharmaceutical to become a blockbuster?
  • Big pharma perspective on radiopharmaceutical investment, partnering, and M&A
  • Next-gen targeted radiopharmaceuticals: targets, targeting technologies, and isotopes
  • Strategic considerations for the choice of radioisotopes
  • Scalable supply chains for radiopharmaceutical manufacturing
  • Regulatory and market access challenges
  • Streamlining radiopharmaceutical clinical trials
  • Theranostics: imaging and artificial intelligence (AI) for personalized therapy
  • Unanswered challenges in targeted radiopharmaceuticals: potential for combination therapies, Alpha vs. Beta emitters, dosimetry models, immune response, etc.

 

If you have a compelling story to share with innovators, investors, and executives attending this boutique event, we encourage you to submit a speaking proposal.

 

Please note that the vast majority of speakers are identified, selected, and invited by our summit chairs and advisory board members. As we receive a high volume of submissions, we regret that Cambridge VIP can only be in contact with those deemed optimal candidates.

 

To become a sponsor, click here.

 

CONFERENCE CONTENT
Julia Boguslavsky
Executive Director, Conferences
juliab@healthtech.com

 

PARTNERING & SPONSORSHIP
Brian Caine
Specialized Business Development Manager
(+1) 908-809-0946
bcaine@healthtech.com